Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pavel A. Levin
Observed names:
P. A Levin,
P. A. Levin,
Pavel A Levin,
Pavel Aleksander Levin,
Pavel Levin
Institution:
Texas Oncology
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Texas Oncology,
Harold C. Simmons Comprehensive Cancer Center,
The University of Texas Southwestern Medical Center
ORCID:
0000-0003-2517-5862
Observed ORCID:
0000-0003-2517-5862
OpenAlex ID:
A5028657986
Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
2008
·
Xue Pan
, Thiruvengadam Arumugam
, et al.
·
Clinical Cancer Research
·
129
PDF
Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition
2015
·
Pavel A. Levin
, Melissa Mayer
, et al.
·
Journal of Thoracic Oncology
·
67
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
2016
·
Pavel A. Levin
, Rolf A. Brekken
, et al.
·
Journal of Thoracic Oncology
·
47
PDF
Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date
2017
·
Pavel A Levin
, Jonathan E Dowell
·
OncoTargets and Therapy
·
21
PDF
1L olomorasib plus pembrolizumab +/- chemotherapy in KRAS G12C-mutant NSCLC patients +/- a prior cycle of SOC: Results from LOXO-RAS 20001 and SUNRAY-01.
2026
·
Timothy F. Burns
, Yutaka Fujiwara
, et al.
·
Journal of Clinical Oncology
·
1
The Use of Crizotinib Neutralizes Differences in Event-Free Survival in Paediatric Patients with Different Morphologic Subtypes of ALK-positive Anaplastic Large Cell Lymphoma
2025
·
Dmitry Abramov
, Anna Fedorova
, et al.
·
OncoDaily Medical Journal
PDF
Supplementary Data from Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
2023
·
Xue Pan
, Thiruvengadam Arumugam
, et al.
PDF
Data from Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
2023
·
Xue Pan
, Thiruvengadam Arumugam
, et al.
Data from Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
2023
·
Xue Pan
, Thiruvengadam Arumugam
, et al.
Supplementary Data from Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
2023
·
Xue Pan
, Thiruvengadam Arumugam
, et al.
Chemotherapy outcomes for unresectable and metastatic biliary tract cancers (BTC): Role of fluoropyrimidine (FP) chemotherapy—A retrospective analysis.
2016
·
Mona Lisa Alattar
, Pavel Levin
, et al.
·
Journal of Clinical Oncology
Abstract 3920: EphA2 transcription is regulated by activation of Ras / MEK2 / cytoplasmic ERK pathway in pancreatic cancer
2010
·
Pavel A. Levin
, Thiruvengadam Arumugam
, et al.
·
Cancer Research
Role and Regulation of EphA2 in Pancreatic Cancer
2010
·
Pavel A. Levin
·
Digital Commons-TMC (Texas Medical Center)
PDF
Silencing of Stat3 Enhances Gemcitabine Mediated Apoptosis in Chemoresistant Pancreatic Cancer Cells
2008
·
X. Pan
, T. Arumugam
, et al.
·
Pancreas
Liposomal Delivery of Epha2 Sirna in Combination With Gemcitabine Reduces Pancreatic Tumor Growth and Invasion
2006
·
P. A. Levin
, T. Arumugam
, et al.
·
Pancreas
Show more works
View as search
Works count:
15
Citation count:
265
H-index:
4
I10-index:
4
Year
Topic
Type
